Drug Type Small molecule drug |
Synonyms Compound Amino-polypeptide, 复方氨肽素 |
Target |
Action antagonists, inhibitors |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists), cGMP-PDE inhibitors(3',5'-cyclic phosphodiesterase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1995), |
Regulation- |
Molecular FormulaC9H16N6O2 |
InChIKeyLHRHXWBJUQKYEL-UHFFFAOYSA-N |
CAS Registry317-34-0 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Psoriasis | China | 01 Jan 1995 |





